98%
921
2 minutes
20
Objective: This study aims to investigate the therapeutic effects of combining pseudomonas aeruginosa injection (PAI) with endostar on patients with malignant pleural effusion and ascites.
Methods: In this prospective study, a total of 105 patients with malignant pleural effusion and ascites admitted to our hospital from January 2019 to April 2022 were selected as research subjects. Among them, 35 patients treated with PAI combined with endostar were enrolled in the observation group, while 35 patients treated with PAI and another 35 patients treated with endostar were enrolled in the control groups. The clinical effectiveness and safety of all three groups were compared, and their relapse-free survival was examined over a period of 90 days.
Results: After treatment, the remission rate and the relapse-free survival of the observation group were higher than those of the control groups ( < 0.05), but there was no difference between the control groups ( > 0.05). The main adverse effect observed was fever, which was more common in the PAI combined with endostar group than in the endostar-only group ( < 0.05).
Conclusion: The clinical treatment of malignant pleural effusion and ascites can be improved by combining pseudomonas aeruginosa injection with endostar. This combination can increase the relapse-free survival of patients and improve the overall safety of treatment.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250978 | PMC |
Background: Actinomyces graevenitzii is a relatively uncommon Actinomyces species, which is an oral species and predominantly recovered from respiratory locations [1,2]. It is a gram-positive anaerobic bacteria or microaerobic filamentation bacteria, which can induce pyogenic and granulomatous inflammation characterized by swelling and concomitant pus, sinus formation, and the formation of yellow sulfur granules. All tissues and organs can be infected; the most common type involves the neck and face (55%), followed by the abdominal and pelvic cavities (20%).
View Article and Find Full Text PDFJTCVS Open
August 2025
Department of Surgery, University at Buffalo, Jacobs School of Medicine and Biomedical Sciences, Buffalo, NY.
Objective: Persistent pulmonary air leak happens in a minority of patients with various thoracic pathologies. Spiration (Olympus America Inc.) bronchial valves (BVs) are approved by the Food and Drug Administration under Humanitarian Use Device status to treat persistent air leak after lung resection.
View Article and Find Full Text PDFDrug Des Devel Ther
September 2025
Department of Anesthesiology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, People's Republic of China.
Purpose: Neoadjuvant immunochemotherapy (NICT) has shown promise in improving the oncological outcomes of locally advanced esophageal cancer (LAEC). However, concerns remain regarding its potential to induce pulmonary side effects that may increase the risk of perioperative adverse events. This study aimed to compare the incidence of postoperative pulmonary complications (PPCs) in patients receiving NICT and those undergoing non-neoadjuvant therapy.
View Article and Find Full Text PDFCureus
August 2025
Respiratory Medicine, Dartford and Gravesham NHS Trust, Dartford, GBR.
Pressure-dependent pneumothorax is an under-recognized but clinically significant phenomenon that complicates pleural fluid drainage, particularly in patients with non-expandable lungs due to malignancy or chronic pleural fibrosis. Unlike pressure-independent pneumothorax, this condition arises from the pronounced transpleural pressure gradient generated during therapeutic thoracentesis or chest drainage. This negative pressure transiently distorts the visceral pleura, allowing air to enter the pleural space until an equilibrium is reached.
View Article and Find Full Text PDFZhonghua Bing Li Xue Za Zhi
September 2025
Department of Pathology, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
To investigate the clinicopathological characteristics of well-differentiated papillary mesothelial tumor (WDPMT). Sixteen cases of resected WDPMTs diagnosed at the Affiliated Hospital of Qingdao University, Qingdao, China from 2017 to 2024 were collected and the clinicopathological features were retrospectively analyzed. There were 7 males amd 9 females, with a mean age of 53.
View Article and Find Full Text PDF